BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11738865)

  • 1. The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome.
    Ishii T; Makita Y; Ogawa A; Amamiya S; Yamamoto M; Miyamoto A; Oki J
    Brain Dev; 2001 Dec; 23 Suppl 1():S161-4. PubMed ID: 11738865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease.
    Villard L; Lévy N; Xiang F; Kpebe A; Labelle V; Chevillard C; Zhang Z; Schwartz CE; Tardieu M; Chelly J; Anvret M; Fontès M
    J Med Genet; 2001 Jul; 38(7):435-42. PubMed ID: 11432961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin.
    Trappe R; Laccone F; Cobilanschi J; Meins M; Huppke P; Hanefeld F; Engel W
    Am J Hum Genet; 2001 May; 68(5):1093-101. PubMed ID: 11309679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots.
    Wan M; Lee SS; Zhang X; Houwink-Manville I; Song HR; Amir RE; Budden S; Naidu S; Pereira JL; Lo IF; Zoghbi HY; Schanen NC; Francke U
    Am J Hum Genet; 1999 Dec; 65(6):1520-9. PubMed ID: 10577905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome.
    Kim SJ; Cook EH
    Hum Mutat; 2000 Apr; 15(4):382-3. PubMed ID: 10737989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation.
    Hammer S; Dorrani N; Hartiala J; Stein S; Schanen NC
    Am J Med Genet A; 2003 Oct; 122A(3):223-6. PubMed ID: 12966522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two affected boys in a Rett syndrome family: clinical and molecular findings.
    Villard L; Kpebe A; Cardoso C; Chelly PJ; Tardieu PM; Fontes M
    Neurology; 2000 Oct; 55(8):1188-93. PubMed ID: 11071498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the gene encoding methyl-CpG-binding protein 2 cause Rett syndrome.
    Van den Veyver IB; Zoghbi HY
    Brain Dev; 2001 Dec; 23 Suppl 1():S147-51. PubMed ID: 11738862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features.
    Auranen M; Vanhala R; Vosman M; Levander M; Varilo T; Hietala M; Riikonen R; Peltonen L; Järvelä I
    Neurology; 2001 Mar; 56(5):611-7. PubMed ID: 11245712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype.
    Chae JH; Hwang H; Hwang YS; Cheong HJ; Kim KJ
    J Child Neurol; 2004 Jul; 19(7):503-8. PubMed ID: 15526954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in fifteen sporadic cases with Rett syndrome].
    Zhu XW; Pan H; Li MR; Bao XH; Zhang JJ; Wu XR
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):565-9. PubMed ID: 19951486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype.
    Weaving LS; Williamson SL; Bennetts B; Davis M; Ellaway CJ; Leonard H; Thong MK; Delatycki M; Thompson EM; Laing N; Christodoulou J
    Am J Med Genet A; 2003 Apr; 118A(2):103-14. PubMed ID: 12655490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of X-chromosome inactivation in the manifestation of Rett syndrome.
    Takagi N
    Brain Dev; 2001 Dec; 23 Suppl 1():S182-5. PubMed ID: 11738869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of MECP2 and determination of the X-inactivation pattern in Hungarian Rett syndrome patients.
    Kárteszi J; Hollódy K; Bene J; Morava E; Hadzsiev K; Czakó M; Melegh B; Tészás A; Kosztolányi G
    Am J Med Genet A; 2004 Nov; 131(1):106. PubMed ID: 15389714
    [No Abstract]   [Full Text] [Related]  

  • 16. Another patient with MECP2 mutation without classic Rett syndrome phenotype.
    Milani D; Pantaleoni C; D'Arrigo S; Selicorni A; Riva D
    Pediatr Neurol; 2005 May; 32(5):355-7. PubMed ID: 15866439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome.
    Amano K; Nomura Y; Segawa M; Yamakawa K
    J Hum Genet; 2000; 45(4):231-6. PubMed ID: 10944854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECP2 and beyond: phenotype-genotype correlations in Rett syndrome.
    Christodoulou J; Weaving LS
    J Child Neurol; 2003 Oct; 18(10):669-74. PubMed ID: 14649547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
    Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
    Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements.
    Longo I; Russo L; Meloni I; Ricci I; Ariani F; Pescucci C; Giordano CT; Canitano R; Hayek G; Zappella M; Neri G; Renieri A; Gurrieri F
    Eur J Hum Genet; 2004 Aug; 12(8):682-5. PubMed ID: 15069458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.